Literature DB >> 34261466

Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China.

Louise T Thomsen1, Susanne K Kjær2,3.   

Abstract

Entities:  

Keywords:  Cancer cervix uteri; Cervical cancer; HPV; Human papillomavirus; Middle income; Prevention; Screening

Year:  2021        PMID： 34261466     DOI： 10.1186/s12916-021-02051-z

Source DB:  PubMed          Journal:  BMC Med        ISSN： 1741-7015            Impact factor:   8.775


× No keyword cloud information.
  7 in total

1.  A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India.

Authors:  Rengaswamy Sankaranarayanan; Bhagwan M Nene; Ketayun A Dinshaw; Cedric Mahe; Kasturi Jayant; Surendra S Shastri; Sylla G Malvi; Roshini Chinoy; Rohini Kelkar; Atul M Budukh; Vijay Keskar; Raghevendra Rajeshwarker; Richard Muwonge; Shubhada Kane; Donald Maxwell Parkin; Madanmohan K Chauhan; Sangeetha Desai; Bernard Fontaniere; Lucien Frappart; Ashok Kothari; Eric Lucas; Nandkumar Panse
Journal:  Int J Cancer       Date:  2005-09-10       Impact factor: 7.396

2.  Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina.

Authors:  Silvina Arrossi; Laura Thouyaret; Rosa Laudi; Oscar Marín; Josefina Ramírez; Melisa Paolino; Rolando Herrero; Alicia Campanera
Journal:  Int J Cancer       Date:  2015-04-15       Impact factor: 7.396

3.  Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.

Authors:  Louise T Thomsen; Susanne K Kjaer; Christian Munk; Dorthe Ørnskov; Marianne Waldstrøm
Journal:  Acta Obstet Gynecol Scand       Date:  2021-03-14       Impact factor: 3.636

4.  The time is now to implement HPV testing for primary screening in low resource settings.

Authors:  Louise Kuhn; Lynette Denny
Journal:  Prev Med       Date:  2017-02-06       Impact factor: 4.018

Review 5.  HPV-FASTER: broadening the scope for prevention of HPV-related cancer.

Authors:  F Xavier Bosch; Claudia Robles; Mireia Díaz; Marc Arbyn; Iacopo Baussano; Christine Clavel; Guglielmo Ronco; Joakim Dillner; Matti Lehtinen; Karl-Ulrich Petry; Mario Poljak; Susanne K Kjaer; Chris J L M Meijer; Suzanne M Garland; Jorge Salmerón; Xavier Castellsagué; Laia Bruni; Silvia de Sanjosé; Jack Cuzick
Journal:  Nat Rev Clin Oncol       Date:  2015-09-01       Impact factor: 66.675

6.  Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study.

Authors:  Clare A Aitken; Heleen M E van Agt; Albert G Siebers; Folkert J van Kemenade; Hubert G M Niesters; Willem J G Melchers; Judith E M Vedder; Rob Schuurman; Adriaan J C van den Brule; Hans C van der Linden; John W J Hinrichs; Anco Molijn; Klaas J Hoogduin; Bettien M van Hemel; Inge M C M de Kok
Journal:  BMC Med       Date:  2019-12-11       Impact factor: 8.775

7.  Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.

Authors:  Guglielmo Ronco; Joakim Dillner; K Miriam Elfström; Sara Tunesi; Peter J F Snijders; Marc Arbyn; Henry Kitchener; Nereo Segnan; Clare Gilham; Paolo Giorgi-Rossi; Johannes Berkhof; Julian Peto; Chris J L M Meijer
Journal:  Lancet       Date:  2013-11-03       Impact factor: 79.321
  7 in total
  2 in total

1.  A comparison of behavioural models explaining cervical cancer screening uptake.

Authors:  Jyoshma Preema Dsouza; Stephan Van den Broucke; Sanjay Pattanshetty; William Dhoore
Journal:  BMC Womens Health       Date:  2022-06-16       Impact factor: 2.742

Review 2.  An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation.

Authors:  Kehinde S Okunade; Adebola A Adejimi; Sarah O John-Olabode; Yusuf A Oshodi; Ayodeji A Oluwole
Journal:  Risk Manag Healthc Policy       Date:  2022-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.